Cover
Cover | Dec. 11, 2023 |
Cover [Abstract] | |
Document Type | 8-K |
Amendment Flag | false |
Document Period End Date | Dec. 11, 2023 |
Entity File Number | 001-36845 |
Entity Registrant Name | Bellerophon Therapeutics, Inc. |
Entity Central Index Key | 0001600132 |
Entity Tax Identification Number | 47-3116175 |
Entity Incorporation, State or Country Code | DE |
Entity Address, Address Line One | c/o Verdolino & Lowey, P.C. |
Entity Address, Address Line Two | 124 Washington Street |
Entity Address, Address Line Three | Suite 101 |
Entity Address, City or Town | Foxborough |
Entity Address, State or Province | MA |
Entity Address, Postal Zip Code | 02035 |
City Area Code | 908 |
Local Phone Number | 574-4770 |
Written Communications | false |
Soliciting Material | false |
Pre-commencement Tender Offer | false |
Pre-commencement Issuer Tender Offer | false |
Title of 12(b) Security | Common Stock, $0.01 par value per share |
Trading Symbol | BLPH |
Security Exchange Name | NASDAQ |
Entity Emerging Growth Company | false |